A new approach for the treatment of CLL using chlorambucil/hydroxychloroquine-loaded anti-CD20 nanoparticles
出版年份 2015 全文链接
标题
A new approach for the treatment of CLL using chlorambucil/hydroxychloroquine-loaded anti-CD20 nanoparticles
作者
关键词
chronic lymphocytic leukemia, immune targeted nanoparticles, treatment, xenograft model
出版物
Nano Research
Volume 9, Issue 2, Pages 537-548
出版商
Springer Nature
发表日期
2015-12-13
DOI
10.1007/s12274-015-0935-3
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Initial treatment of CLL: integrating biology and functional status
- (2015) N. Jain et al. BLOOD
- Targeted therapies in CLL: mechanisms of resistance and strategies for management
- (2015) J. A. Woyach et al. BLOOD
- State-of-the-art in design rules for drug delivery platforms: Lessons learned from FDA-approved nanomedicines
- (2014) Charlene M. Dawidczyk et al. JOURNAL OF CONTROLLED RELEASE
- Bispecific antibodies targeting tumor-associated antigens and neutralizing complement regulators increase the efficacy of antibody-based immunotherapy in mice
- (2014) P Macor et al. LEUKEMIA
- Chronic lymphocytic leukemia: 2013 update on diagnosis, risk stratification and treatment
- (2013) Michael Hallek AMERICAN JOURNAL OF HEMATOLOGY
- New Potential Therapeutic Approach for the Treatment of B-Cell Malignancies Using Chlorambucil/Hydroxychloroquine-Loaded Anti-CD20 Nanoparticles
- (2013) Nelly Mezzaroba et al. PLoS One
- Xenograft models of chronic lymphocytic leukemia: problems, pitfalls and future directions
- (2012) M T S Bertilaccio et al. LEUKEMIA
- Nanoparticle Delivery of Cancer Drugs
- (2011) Andrew Z. Wang et al. Annual Review of Medicine
- Principles and Current Strategies for Targeting Autophagy for Cancer Treatment
- (2011) R. K. Amaravadi et al. CLINICAL CANCER RESEARCH
- The Lysosomotropic Agent, Hydroxychloroquine, Delivered in a Biodegradable Nanoparticle System, Overcomes Drug Resistance of B-Chronic Lymphocytic Leukemia Cells In Vitro
- (2010) Eduardo Mansilla et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Interaction of the Retinoblastoma Protein with Orc1 and Its Recruitment to Human Origins of DNA Replication
- (2010) Ramiro Mendoza-Maldonado et al. PLoS One
- Hydroxychloroquine, chloroquine, and all-trans retinoic acid regulate growth, survival, and histone acetylation in breast cancer cells
- (2009) Rayhana Rahim et al. ANTI-CANCER DRUGS
- P-Selectin Glycoprotein Ligand-1 as a Potential Target for Humoral Immunotherapy of Multiple Myeloma (Supplementry Material)
- (2009) C. Tripodo et al. CURRENT CANCER DRUG TARGETS
- Biodegradable PLGA based nanoparticles for sustained regional lymphatic drug delivery
- (2009) Deepa A. Rao et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Effects of the Antlered Form ofGanoderma lucidumon Tumor Growth and Metastasis in Cyclophosphamide-Treated Mice
- (2008) Yuji NONAKA et al. BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY
- An Update on the Xenograft and Mouse Models Suitable for Investigating New Therapeutic Compounds for the Treatment of B-Cell Malignancies
- (2008) Paolo Macor et al. CURRENT PHARMACEUTICAL DESIGN
- Ocular Toxicity of Hydroxychloroquine
- (2008) Rodney Tehrani et al. Seminars in Ophthalmology
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now